Autism treatment provider organization Cortica, Inc. closed a $75 million financing round and acquired Springtide Child Development and Melmed Center. The funding round was led by Deerfield Management and Optum Ventures. Additional new investors include RA Capital Management and Echo Health Ventures, alongside existing Cortica investors Longitude Capital, .406 Ventures, Questa Capital, Ajax Health, Aperture Venture Partners, and the Autism Impact Fund.

Both Springtide and Melmed Center provide autism treatment. With these two acquisitions, Cortica owns and operates 23 integrated autism centers across the country. Springtide provides autism treatment services in the Northeastern U.S. Springtide's investors have rolled . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!